S-3 EX-FILING FEES 0001652935 N/A N/A 0001652935 1 2025-09-02 2025-09-02 0001652935 2 2025-09-02 2025-09-02 0001652935 3 2025-09-02 2025-09-02 0001652935 4 2025-09-02 2025-09-02 0001652935 5 2025-09-02 2025-09-02 0001652935 6 2025-09-02 2025-09-02 0001652935 2025-09-02 2025-09-02 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-3

Actuate Therapeutics, Inc.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Debt   Debt Securities       457(o)       $     $     0.0001531   $  
Fees to be Paid   Equity   Preferred Stock, par value $0.000001 per share       457(o)                   0.0001531      
Fees to be Paid   Equity   Common Stock, par value $0.000001 per share       457(o)                   0.0001531      
Fees to be Paid   Other   Warrants       457(o)                   0.0001531      
Fees to be Paid   Other   Units       457(o)                   0.0001531      
Fees to be Paid   Unallocated (Universal) Shelf       (1)   457(o)       $     $ 250,000,000.00   0.0001531   $ 38,275.00
                                           
Total Offering Amounts:   $ 250,000,000.00         38,275.00
Total Fees Previously Paid:                
Total Fee Offsets:               0.00
Net Fee Due:             $ 38,275.00

__________________________________________
Offering Note(s)

(1) Separate consideration may or may not be received for securities that are issuable upon the conversion or exercise of, or in exchange for, other securities offered hereby.

There are being registered hereunder such indeterminate number of shares of common stock and preferred stock, such indeterminate principal amount of debt securities, such indeterminate number of warrants to purchase common stock, preferred stock and/or debt securities, and such indeterminate number of units to be sold by the Registrant from time to time at unspecified prices which shall have an aggregate initial offering price not to exceed $250,000,000. If any debt securities are issued at an original issue discount, then the principal amount of such debt securities shall be in such greater amount as shall result in an aggregate initial offering price not to exceed $250,000,000, less the aggregate dollar amount of all securities previously issued hereunder. The securities registered for sale also include such indeterminate number of shares of common stock and preferred stock and amount of debt securities as may be issued upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the antidilution provisions of any such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares being registered hereunder include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.

The proposed maximum offering price per share will be determined, from time to time, by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Instruction 2.A.iii.b. to the Calculation of Filing Fee Tables and Related Disclosure on Item 16(b) of Form S-3 under the Securities Act.
The proposed maximum aggregate offering price has been calculated pursuant to Rule 457(o) under the Securities Act.